Personalizing Medicine for Pediatric Brain Cancer
Sanford Burnham Prebys presents Insights: Personalizing Medicine for Pediatric Brain Cancer: Medulloblastoma is the most common malignant brain tumor in children. The standard treatments for these diseases are surgery, whole brain and spine radiation, and intensive chemotherapy. Although these aggressive treatments can cure some patients, one in four patients dies from the disease, and those who survive often suffer devastating long-term side effects, which include intellectual disability, hormonal disorders and an increased risk of other cancers. Safer and more effective therapies are desperately needed, and treatment advances cannot come soon enough for these vulnerable pediatric patients. Join Sanford Burnham Prebys’ Dr. Robert Wechsler-Reya and Rady Children's Hospital-San Diego’s Dr. John Crawford to learn about the latest efforts in developing better treatments for pediatric brain cancer.